Psychedelic Drugs Market: Analysis and Review 2021

Date : May 2021 Pages : 113 Category : Healthcare and Pharmaceutical
Single User - $2999 Enterprise User - $4999 Buy Report

Abstract - According to the report published by Elint Insights, global demand for Psychedelic Drugs market was valued at approximately USD 4.75 Billion in 2020, and is expected to generate revenue of around USD 10.75 Billion by end of 2027, growing at a CAGR of around 12.3% between 2021 and 2027.

What the Report Offer? - The newly added detailed report on Global Psychedelic Drugs Market present with the vision to shape the future of related businesses. Our research analysts have studied the report thoroughly on various aspects including market overview, growth rate, driving forces, market size, market trends, challenges, opportunities and competitive analysis on the global and regional basis. The Psychedelic Drugs market research report provides a detailed analysis of the global market outlook and focuses on leading players, applications, and product/service types. The report offers insights into the market trends and highlights key industry product developments. Additionally, the report compiles several factors that have attributed to the market’s growth over recent years.

COVID Impact - COVID-19 pandemic resulted in worldwide lockdown which impacted several major economies. This has hampered the sale of Psychedelic Drugs products as well as disturbed the supply-demand chain. Further, many economies are suffering a drastic revenue loss due to shutdown of several industries. The overall situation has certainly affected the demand of Psychedelic Drugs in the past year.

Leading Players - Prominent market players have been profiled to get better insights into the global businesses. Our report offers comprehensive information on different top-level manufacturers which are functioning in global regions. The company profiles under this section includes informative data such as company overview, contact/business information, and some significant strategies followed by them.

COMPASS

The Emmes Company
Klarisana
AstraZeneca
F. Hoffmann-La Roche Ltd
Dr. Reddy’s Laboratories Ltd
Takeda Pharmaceutical Company Limited
Pfizer Inc
Mylan N.V.
Merck & Co., Inc
Alkermes
ALLERGAN

Psychedelic Drugs Market Segmentation - Psychedelic Drugs research report forecasts revenue growth at global, regional, and country levels. The report provides an analysis of the trending and latest market dynamics in each of the segments from 2017 to 2027. This report has been aggregated on the basis of various market segments and sub-segments associated with the international market. Global Psychedelic Drugs Market Key Segments:

On the Basis of Type:
Dissociatives
Empathogens
Serotonergic

On the Basis of Application:
Major Depressive Disorder

Resistant depression
Panic disorder
Post-traumatic stress disorder
Opiate Addiction

On the Basis of Region:
North America
Europe
Asia-Pacific
Latin America
Middle East and Africa (MEA)

Research Snapshot
Historic Period: 2015 – 2020
Base Year: 2021
Forecast Period: 2021-2027

The study provides the most comprehensive and up-to-date information and analysis on the future of the Psychedelic Drugs markets, including the dynamics, growth factors and challenges of the worldwide Psychedelic Drugs outlook. Additionally, the report covers the entire spectrum of the Psychedelic Drugs value chain from upstream to downstream all the way through to insights and data across the globe. With in-depth analysis, recent developments and reliable detailed databases at your fingertips the report gives complete 360 view into the Psychedelic Drugs industry.

Why buy this report on the global Psychedelic Drugs market?
Key industry trends
Threats and opportunities analysis
Effective decision making
Competitive intelligence analysis


What’s included in this study?
Global Market Outlook
Recent Developments
Future Opportunities
Post-Covid Scenario
Analyst View

Psychedelic Drugs Research Study at a Glance
Industry Overview
Market Dynamics
Industry Performance
COVID Impact
Product/Service Outlook
Geographical Analysis
Competitive Landscape
Leading Player
Financial Statistics
Conclusion

Why Elint Insights? - Our database includes thousands of reports on various industries around the world. The research studies help our clients with relevant information and data to stay up-to-date on industry trends. With this Research Report on Psychedelic Drugs, you will get a thoroughly researched, reliable industry information that will help you to make faster and strategic business decisions. This studies also enable decision-makers to use marketing analysis in more innovative and meaningful manner.

Table of Contents Chapter 1 Executive Summary 1.1. Introduction of Psychedelic Drugs Market 1.2. Global Psychedelic Drugs Market, 2019 & 2026 (USD Million) 1.3. Global Psychedelic Drugs Market, 2016 – 2026 (USD Million) 1.4. Global Psychedelic Drugs Market Absolute Revenue Opportunity, 2016 – 2026 (USD Million) 1.5. Global Psychedelic Drugs Market Incremental Revenue Opportunity, 2020 – 2026 (USD Million) 1.6. COVID-19 Impacts on Psychedelic Drugs Market 1.7. COVID-19 Impact on the Players 1.8. Business Strategies and Recommendations Chapter 2 Psychedelic Drugs Market – By Type Analysis 2.1. Global Psychedelic Drugs Market – By Type Overview 2.2. Global Psychedelic Drugs Market Share, By Type, 2019 & 2026 (USD Million) 2.3. Dissociatives
2.3.1. Global Dissociatives Psychedelic Drugs Market, 2017 – 2027 (USD Million)
2.4. Empathogens
2.4.1. Global Empathogens Psychedelic Drugs Market, 2017 – 2027 (USD Million)
2.5. Serotonergic
2.5.1. Global Serotonergic Psychedelic Drugs Market, 2017 – 2027 (USD Million)
Chapter 3 Psychedelic Drugs Market – By Application Analysis 3.1. Global Psychedelic Drugs Market – By Application Overview 3.2. Global Psychedelic Drugs Market Share, By Application, 2019 & 2026 (USD Million) 3.3. Major Depressive Disorder
3.3.1. Global Major Depressive Disorder Psychedelic Drugs Market, 2017 – 2027 (USD Million)
3.3.2. Use – Cases for Major Depressive Disorder
3.4. Resistant depression
3.4.1. Global Resistant depression Psychedelic Drugs Market, 2017 – 2027 (USD Million)
3.4.2. Use – Cases for Resistant depression
3.5. Panic disorder
3.5.1. Global Panic disorder Psychedelic Drugs Market, 2017 – 2027 (USD Million)
3.5.2. Use – Cases for Panic disorder
3.6. Post-traumatic stress disorder
3.6.1. Global Post-traumatic stress disorder Psychedelic Drugs Market, 2017 – 2027 (USD Million)
3.6.2. Use – Cases for Post-traumatic stress disorder
3.7. Opiate Addiction
3.7.1. Global Opiate Addiction Psychedelic Drugs Market, 2017 – 2027 (USD Million)
3.7.2. Use – Cases for Opiate Addiction
Chapter 4 Psychedelic Drugs Market – Regional Analysis 4.1. Global Psychedelic Drugs Market Regional Overview 4.2. Global Psychedelic Drugs Market Share, by Region, 2019 & 2026 (USD Million) 4.3. North America 4.3.1. North America Psychedelic Drugs Market, 2016 – 2026 (USD Million) 4.3.1.1. North America Psychedelic Drugs Market, by Country, 2016 - 2026 (USD Million) 4.3.2. North America Psychedelic Drugs Market, By Type, 2016 – 2026 4.3.2.1. North America Psychedelic Drugs Market, By Type, 2016 – 2026 (USD Million) 4.3.3. North America Psychedelic Drugs Market, By Application, 2016 – 2026 4.3.3.1. North America Psychedelic Drugs Market, By Application, 2016 – 2026 (USD Million) 4.3.4. U.S. 4.3.4.1. U.S. Psychedelic Drugs Market, 2016 – 2026 (USD Million) 4.3.5. Canada 4.3.5.1. Canada Psychedelic Drugs Market, 2016 – 2026 (USD Million) 4.4. Europe 4.4.1. Europe Psychedelic Drugs Market, 2016 – 2026 (USD Million) 4.4.1.1. Europe Psychedelic Drugs Market, by Country, 2016 - 2026 (USD Million) 4.4.2. Europe Psychedelic Drugs Market, By Type, 2016 – 2026 4.4.2.1. Europe Psychedelic Drugs Market, By Type, 2016 – 2026 (USD Million) 4.4.3. Europe Psychedelic Drugs Market, By Application, 2016 – 2026 4.4.3.1. Europe Psychedelic Drugs Market, By Application, 2016 – 2026 (USD Million) 4.4.4. Germany 4.4.4.1. Germany Psychedelic Drugs Market, 2016 – 2026 (USD Million) 4.4.5. France 4.4.5.1. France Psychedelic Drugs Market, 2016 – 2026 (USD Million) 4.4.6. U.K. 4.4.6.1. U.K. Psychedelic Drugs Market, 2016 – 2026 (USD Million) 4.4.7. Italy 4.4.7.1. Italy Psychedelic Drugs Market, 2016 – 2026 (USD Million) 4.4.8. Spain 4.4.8.1. Spain Psychedelic Drugs Market, 2016 – 2026 (USD Million) 4.4.9. Portugal 4.4.9.1. Portugal Psychedelic Drugs Market, 2016 – 2026 (USD Million) 4.4.10. Cyprus 4.4.10.1. Cyprus Psychedelic Drugs Market, 2016 – 2026 (USD Million) 4.4.11. Lithuania 4.4.11.1. Lithuania Psychedelic Drugs Market, 2016 – 2026 (USD Million) 4.4.12. Greece 4.4.12.1. Greece Psychedelic Drugs Market, 2016 – 2026 (USD Million) 4.4.13. Rest of Europe 4.4.13.1. Rest of Europe Psychedelic Drugs Market, 2016 – 2026 (USD Million) 4.5. Asia Pacific 4.5.1. Asia Pacific Psychedelic Drugs Market, 2016 – 2026 (USD Million) 4.5.1.1. Asia Pacific Psychedelic Drugs Market, by Country, 2016 - 2026 (USD Million) 4.5.2. Asia Pacific Psychedelic Drugs Market, By Type, 2016 – 2026 4.5.2.1. Asia Pacific Psychedelic Drugs Market, By Type, 2016 – 2026 (USD Million) 4.5.3. Asia Pacific Psychedelic Drugs Market, By Application, 2016 – 2026 4.5.3.1. Asia Pacific Psychedelic Drugs Market, By Application, 2016 – 2026 (USD Million) 4.5.4. China 4.5.4.1. China Psychedelic Drugs Market, 2016 – 2026 (USD Million) 4.5.5. Japan 4.5.5.1. Japan Psychedelic Drugs Market, 2016 – 2026 (USD Million) 4.5.6. India 4.5.6.1. India Psychedelic Drugs Market, 2016 – 2026 (USD Million) 4.5.7. South Korea 4.5.7.1. South Korea Psychedelic Drugs Market, 2016 – 2026 (USD Million) 4.5.8. Rest of Asia Pacific 4.5.8.1. Rest of Asia Pacific Psychedelic Drugs Market, 2016 – 2026 (USD Million) 4.6. Latin America 4.6.1. Latin America Psychedelic Drugs Market, 2016 – 2026 (USD Million) 4.6.1.1. Latin America Psychedelic Drugs Market, by Country, 2016 - 2026 (USD Million) 4.6.2. Latin America Psychedelic Drugs Market, By Type, 2016 – 2026 4.6.2.1. Latin America Psychedelic Drugs Market, By Type, 2016 – 2026 (USD Million) 4.6.3. Latin America Psychedelic Drugs Market, By Application, 2016 – 2026 4.6.3.1. Latin America Psychedelic Drugs Market, By Application, 2016 – 2026 (USD Million) 4.6.4. Brazil 4.6.4.1. Brazil Psychedelic Drugs Market, 2016 – 2026 (USD Million) 4.6.5. Mexico 4.6.5.1. Mexico Psychedelic Drugs Market, 2016 – 2026 (USD Million) 4.6.6. Rest of Latin America 4.6.6.1. Rest of Latin America Psychedelic Drugs Market, 2016 – 2026 (USD Million) 4.7. The Middle-East and Africa 4.7.1. The Middle-East and Africa Psychedelic Drugs Market, 2016 – 2026 (USD Million) 4.7.1.1. The Middle-East and Africa Psychedelic Drugs Market, by Country, 2016 - 2026 (USD Million) 4.7.2. The Middle-East and Africa Psychedelic Drugs Market, By Type, 2016 – 2026 4.7.2.1. The Middle-East and Africa Psychedelic Drugs Market, By Type, 2016 – 2026 (USD Million) 4.7.3. The Middle-East and Africa Psychedelic Drugs Market, By Application, 2016 – 2026 4.7.3.1. The Middle-East and Africa Psychedelic Drugs Market, By Application, 2016 – 2026 (USD Million) 4.7.4. GCC Countries 4.7.4.1. GCC Countries Psychedelic Drugs Market, 2016 – 2026 (USD Million) 4.7.5. South Africa 4.7.5.1. South Africa Psychedelic Drugs Market, 2016 – 2026 (USD Million) 4.7.6. Rest of Middle-East Africa 4.7.6.1. Rest of Middle-East Africa Psychedelic Drugs Market, 2016 – 2026 (USD Million) Chapter 5 Psychedelic Drugs Market – Competitive Landscape 5.1. Competitor Market Share – Revenue 5.2. Strategic Developments 5.2.1. Acquisitions and Mergers 5.2.2. New Products 5.2.3. Research & Development Activities Chapter 6 Company Profiles 6.1. COMPASS
6.1.1. Company Overview
6.1.2. Product/Service Portfolio
6.1.3. COMPASS Sales, Revenue, and Gross Margin
6.1.4. COMPASS Revenue and Growth Rate
6.1.5. COMPASS Psychedelic Drugs Market Share
6.2. The Emmes Company
6.2.1. Company Overview
6.2.2. Product/Service Portfolio
6.2.3. The Emmes Company Sales, Revenue, and Gross Margin
6.2.4. The Emmes Company Revenue and Growth Rate
6.2.5. The Emmes Company Psychedelic Drugs Market Share
6.3. Klarisana
6.3.1. Company Overview
6.3.2. Product/Service Portfolio
6.3.3. Klarisana Sales, Revenue, and Gross Margin
6.3.4. Klarisana Revenue and Growth Rate
6.3.5. Klarisana Psychedelic Drugs Market Share
6.4. AstraZeneca
6.4.1. Company Overview
6.4.2. Product/Service Portfolio
6.4.3. AstraZeneca Sales, Revenue, and Gross Margin
6.4.4. AstraZeneca Revenue and Growth Rate
6.4.5. AstraZeneca Psychedelic Drugs Market Share
6.5. F. Hoffmann-La Roche Ltd
6.5.1. Company Overview
6.5.2. Product/Service Portfolio
6.5.3. F. Hoffmann-La Roche Ltd Sales, Revenue, and Gross Margin
6.5.4. F. Hoffmann-La Roche Ltd Revenue and Growth Rate
6.5.5. F. Hoffmann-La Roche Ltd Psychedelic Drugs Market Share
6.6. Dr. Reddy’s Laboratories Ltd
6.6.1. Company Overview
6.6.2. Product/Service Portfolio
6.6.3. Dr. Reddy’s Laboratories Ltd Sales, Revenue, and Gross Margin
6.6.4. Dr. Reddy’s Laboratories Ltd Revenue and Growth Rate
6.6.5. Dr. Reddy’s Laboratories Ltd Psychedelic Drugs Market Share
6.7. Takeda Pharmaceutical Company Limited
6.7.1. Company Overview
6.7.2. Product/Service Portfolio
6.7.3. Takeda Pharmaceutical Company Limited Sales, Revenue, and Gross Margin
6.7.4. Takeda Pharmaceutical Company Limited Revenue and Growth Rate
6.7.5. Takeda Pharmaceutical Company Limited Psychedelic Drugs Market Share
6.8. Pfizer Inc
6.8.1. Company Overview
6.8.2. Product/Service Portfolio
6.8.3. Pfizer Inc Sales, Revenue, and Gross Margin
6.8.4. Pfizer Inc Revenue and Growth Rate
6.8.5. Pfizer Inc Psychedelic Drugs Market Share
6.9. Mylan N.V.
6.9.1. Company Overview
6.9.2. Product/Service Portfolio
6.9.3. Mylan N.V. Sales, Revenue, and Gross Margin
6.9.4. Mylan N.V. Revenue and Growth Rate
6.9.5. Mylan N.V. Psychedelic Drugs Market Share
6.10. Merck & Co. Inc
6.10.1. Company Overview
6.10.2. Product/Service Portfolio
6.10.3. Merck & Co. Inc Sales, Revenue, and Gross Margin
6.10.4. Merck & Co. Inc Revenue and Growth Rate
6.10.5. Merck & Co. Inc Psychedelic Drugs Market Share
6.11. Alkermes
6.11.1. Company Overview
6.11.2. Product/Service Portfolio
6.11.3. Alkermes Sales, Revenue, and Gross Margin
6.11.4. Alkermes Revenue and Growth Rate
6.11.5. Alkermes Psychedelic Drugs Market Share
6.12. ALLERGAN
6.12.1. Company Overview
6.12.2. Product/Service Portfolio
6.12.3. ALLERGAN Sales, Revenue, and Gross Margin
6.12.4. ALLERGAN Revenue and Growth Rate
6.12.5. ALLERGAN Psychedelic Drugs Market Share
Chapter 7 Psychedelic Drugs Market — Industry Analysis 7.1. Introduction and Taxonomy 7.2. Psychedelic Drugs Market – Key Trends 7.2.1. Market Drivers 7.2.2. Market Restraints 7.2.3. Market Opportunities 7.3. Value Chain Analysis 7.4. Porter’s Five Force Analysis for Global Psychedelic Drugs Market 7.5. Technology Roadmap and Timeline 7.5.1. Go-To-Market Strategy Framework 7.5.1.1. For Europe 7.5.1.2. For Global Perspective 7.6. Psychedelic Drugs Market – Attractiveness Analysis 7.6.1. By Application 7.6.2. By Region 7.7. Marketing Channel Analysis – Psychedelic Drugs Market 7.7.1. Direct Marketing 7.7.2. Indirect Marketing 7.8. Patent Analysis (Subject to Data Availability) Chapter 8 Report Conclusion & Key Insights 8.1. Key Insights from Primary Interviews & Surveys Respondents 8.2. Key Takeaways from Analysts, Consultants, and Industry Leaders Chapter 9 References Chapter 10 Research Approach & Methodology 10.1. Report Description 10.2. Research Scope 10.3. Research Methodology 10.3.1. Secondary Research 10.3.2. Primary Research 10.3.3. Statistical Models 10.3.3.1. Company Share Analysis Model 10.3.3.2. Revenue Based Modeling 10.3.4. Research Limitations

Related Reports